SNNC
Sibannac, Inc.
Key Financials
Net Income
$-351019
↑ 85.2%
Gross Profit
$70382
↑ Infinity%
Operating Income
$-199384
↓ 49.9%
Revenue
$523677
↑ Infinity%
Total Assets
$322771.00
↓ 42.9%
Total Liabilities
$615600.00
↑ 21.5%
Cash & Equivalents
$63000.00
↑ 1678.7%
Shareholders' Equity
$-292829.00
↓ 603.2%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| QUALIF | 5/22/2024 | View on SEC |
| CORRESP | 5/21/2024 | View on SEC |
| CORRESP | 5/20/2024 | View on SEC |
| 1-A POS | 5/10/2024 | View on SEC |
| CORRESP | 5/9/2024 | View on SEC |
| UPLOAD | 4/29/2024 | View on SEC |
| CORRESP | 4/12/2024 | View on SEC |
| 1-A POS | 4/12/2024 | View on SEC |
| UPLOAD | 2/29/2024 | View on SEC |
| 1-A POS | 2/2/2024 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | SNNC |
| Company Name | Sibannac, Inc. |
| CIK | 1313938 |
| Sector | Pharmaceutical Preparations |
| Industry | Smaller reporting company |
| Exchange | OTC |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 0831 |
| State of Incorporation | NV |
| Phone | 480-498-8300 |